Seminars in Hematology
Volume 47, Issue 2 , Pages 148-155 , April 2010

Rituximab in High-Grade Lymphoma

  • Carsten Zwick
    • ,
  • Niels Murawski
    • ,
  • Michael Pfreundschuh

      Affiliations

    • Corresponding Author InformationAddress correspondence to Michael Pfreundschuh, MD, Klinik für Innere Medizin I, Saarland University Medical School, D-66421 Homburg (Saar), Germany
    • ,
  • German High-Grade Non-Hodgkin Lymphoma Study Group

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Financial disclosure: M.P. is on the Roche Mabthera Advisory Board and has received unrestricted grants from Roche.

PII: S0037-1963(10)00009-0

doi: 10.1053/j.seminhematol.2010.01.008

Seminars in Hematology
Volume 47, Issue 2 , Pages 148-155 , April 2010

Article Tools

* Image Usage & Resolution